Effect of Gojihvadi Syrup and Anu Taila Nasya in managing childhod recurrent cold

Phase 2/3

Not yet recruiting

• Conditions: Childhood Allergic Rhinitis

• Registration Number: CTRI/2018/05/014165
• Lead Sponsor: ALL INDIA INSTITUTE OF AYURVEDA

Brief Summary

This study is a randomized comparative interventional parallel group clinical trial comparing the therapeutic efficacy and to evaluate the anti-allergic and immuno-modulatory effect of *ANU TAIL NASYA (2 drops daily*) with or without *GOJIHVADI* Syrup daily in doses as per the patient’s age for a period of 6 weeks in 100 patients of Respiratory Allergic Disorder that will be conducted in All India Institute of Ayurveda, Gautam Puri, Sarita Vihar, New Delhi. The primary endpoint measures will be reduction in the severity score of Allergic rhinitis assessed after 6 weeks of treatment. The secondary endpoint will be changes in the Quality of Life of children in both the groups.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2018-05-23
• Study Start: 2018-05-29

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Presence of Cardinal features of Pratishaya like kasa, Nasa Srava, Ghranoparodha, Gandhagyan, Galashotha, Shwaskashtata, Akshikandu, Sashabdaswaas, Shirahshoola, Jwara, Kshwathu, Swarasada.
• Recurrence of at least one episode every month for last one year or more.
• Patients who are willing to participate in the study and come for follow up.

Exclusion Criteria

• Severe and Complicated respiratory allergic disorders.
• Other respiratory infectious conditions such as Tuberculosis, Plural effusion, Emphysema, Lung abscess, Bronchieactasis, pneumonia, Pleurisy.
• Upper Respiratory complaints such as Nasal polyposis, Nasal tumours.
• Congenital anomalies of respiratory tract.
• Children with chronic debilitating diseases like JDM, HIV, HBsAg, immune compromised children etc.
• Patients who are not willing to be included in the study protocol and also who are not willing to give the consent for the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction in severity score of Allergic rhinitis.	Reduction in severity score of Allergic rhinitis.

Secondary Outcome Measures

Name	Time	Method
Changes in the Quality of Life of children in both the groups according to WHO.	at the end of the study

Trial Locations

Locations (1)

ALL INDIA INSTITUTE OF AYURVEDA; 🇮🇳 West, DELHI, India

ALL INDIA INSTITUTE OF AYURVEDA

🇮🇳West, DELHI, India

Manisha Agrawal

Principal investigator

9711681024

manisha.agarwal089@gmail.com